ADVERTISEMENT

Dabur India Q4 Results Review: Dolat Capital Upgrades The Stock To 'Buy' But Cuts Target Price — Here's Why

Considering the recent fall in stock price and anticipated recovery, Dolat Capital upgrades Dabur to ‘Buy’ rating.

<div class="paragraphs"><p>Dabur India's revenues grew by 0.6% YoY to Rs 28.3 billion (5-year CAGR of 8.7%). (Source: Company website)</p></div>
Dabur India's revenues grew by 0.6% YoY to Rs 28.3 billion (5-year CAGR of 8.7%). (Source: Company website)
Dabur exhibited mixed segmental performance across segments - In HPC, skin care posted 8.0% growth, while home care posted flattish growth. However, hair care/oral care de-grew by 4.6/5.2%. In healthcare segment, digestives/ health supplements/OTC & Ethical de-grew by 2.1/8.4/3.6%. Moreover, food and beverages de-grew by 9.2%, while foods/Badshah grew by 14.2/6%. Going ahead, Dolat Capital believes that most segments will continue to...
To continue reading this story
You must be an existing Premium User
OUR NEWSLETTERS
By signing up you agree to the Terms & Conditions of NDTV Profit